CSHP eBulletin



March 7, 2019

Many Thanks to the CSHP Foundation's 2018 Supporters!

By: Amanda Iannaccio

The CSHP Foundation Board of Trustees would like to acknowledge and thank the many corporations and CSHP members who generously provided financial support to the Foundation in 2018.  Corporate Donors Bronze ($10,000 - $19,999)
Astra Zeneca Canada Inc.
Pfizer Canada …




March 7, 2019

Introducing CSHP’s Choosing Wisely Canada Recommendations

  The Choosing Wisely Canada national campaign aims to help clinicians and patients engage in conversations about unnecessary tests and treatments, and make smart and effective care choices. CSHP is happy to present the member-generated recommendations for consideration when striving for…


March 7, 2019

CSHP’s Controlled Drugs and Substances in Hospitals and Healthcare Facilities: Guidelines on Secure Management and Diversion Prevention are Now Available – Learn More Here!

By: Amanda Iannaccio

Across Canada, the opioid crisis is affecting patients, families, the general public, and the healthcare system. The number of deaths attributed to the crisis is staggering. CSHP joined Health Canada, provincial ministries of health, health agencies, health professio…




February 15, 2019

Pharmacists across Canada are Encouraged to Complete the Questionnaire: What do YOU think the role of hospital pharmacists as immunizers should be?

By: Amanda Iannaccio

The purpose of this questionnaire is to conduct an environmental scan to characterize pharmacists’ roles in providing vaccine education, facilitating others in the provision vaccines, and/or administering vaccines. It will also examine the opinions surrounding immunization, as well as…


February 15, 2019

Important – Health Canada Policy Statement on the Naming of Biologic Drugs/Important - Énoncé de politique sur l’attribution de noms aux médicaments biologiques de Santé Canada

By: Amanda Iannaccio

Health Canada is pleased to announce a decision on the naming of biologic drugs. Following internal and external stakeholder consultations and analysis of related issues, Health Canada has decided that biologic drugs, including biosimilars, will be identified by their unique brand name and n…